awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34506788-91BE119C-35A4-444D-9691-C813FEE3B862
Q34506788-91BE119C-35A4-444D-9691-C813FEE3B862
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34506788-91BE119C-35A4-444D-9691-C813FEE3B862
Potent Antiviral Activities of the Direct-Acting Antivirals ABT-493 and ABT-530 with Three-Day Monotherapy for Hepatitis C Virus Genotype 1 Infection
P2860
Q34506788-91BE119C-35A4-444D-9691-C813FEE3B862
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34506788-91BE119C-35A4-444D-9691-C813FEE3B862
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2d6e72ef71dd1fdddc0514dd9d6d4bf9b56e8fa7
P2860
A phase 1, randomized, placebo-controlled, 3-day, dose-ranging study of GS-5885, an NS5A inhibitor, in patients with genotype 1 hepatitis C.